Clinical Trial Update: Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for liposomal irinotinecan with carboplatin or oxaliplatin in esophageal cancer; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• OXALIPLATIN (Oxaliplatin)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Esophageal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING